ISBN 10: 1627039147 / ISBN 13: 9781627039147
Gebraucht / Anzahl: 0
Bei weiteren Verkäufern erhältlich
Alle  Exemplare dieses Buches anzeigen

Über dieses Buch

Leider ist dieses Exemplar nicht mehr verfügbar. Wir haben Ihnen weitere Exemplare dieses Titels unten aufgelistet.

Beschreibung:

This Book is in Good Condition. Clean Copy With Light Amount of Wear. 100% Guaranteed. Buchnummer des Verkäufers

Über diesen Titel:

Inhaltsangabe:

Over the past decade, significant efforts have been made to develop stem cell-based therapies for difficult to treat diseases. Multipotent mesenchymal stromal cells, also referred to as mesenchymal stem cells (MSCs), appear to hold great promise in regards to a regenerative cell-based therapy for the treatment of these diseases. Currently, more than 200 clinical trials are underway worldwide exploring the use of MSCs for the treatment of a wide range of disorders including bone, cartilage and tendon damage, myocardial infarction, graft-versus-host disease, Crohn?s disease, diabetes, multiple sclerosis, critical limb ischemia and many others.

 

MSCs were first identified by Friendenstein and colleagues as an adherent stromal cell population within the bone marrow with the ability to form clonogenic colonies in vitro.  In regards to the basic biology associated with MSCs, there has been tremendous progress towards understanding this cell population?s phenotype and function from a range of tissue sources.  Despite enormous progress and an overall increased understanding of MSCs at the molecular and cellular level, several critical questions remain to be answered in regards to the use of these cells in therapeutic applications.  Clinically, both autologous and allogenic approaches for the transplantation of MSCs are being explored.  Several of the processing steps needed for the clinical application of MSCs, including isolation from various tissues, scalable in vitro expansion, cell banking, dose preparation, quality control parameters, delivery methods and numerous others are being extensively studied.   Despite a significant number of ongoing clinical trials, none of the current therapeutic approaches have, at this point, become a standard of care treatment.  Although exceptionally promising, the clinical translation of MSC-based therapies is still a work in progress.

 

The extensive number of ongoing clinical trials is expected to provide a clearer path forward for the realization and implementation of MSCs in regenerative medicine. Towards this end, reviews of current clinical trial results and discussions of relevant topics association with the clinical application of MSCs are compiled in this book from some of the leading researchers in this exciting and rapidly advancing field.  Although not absolutely all-inclusive, we hope the chapters within this book can promote and enable a better understanding of the translation of MSCs from bench-to-bedside and inspire researchers to further explore this promising and quickly evolving field.

Klappentext:

Mesenchymal Stem Cells or Multipotent Mesenchymal Stromal Cells (collectively referred to as MSCs) are currently being tested in a number of clinical trials for various diseases including graft-versus-host disease, Crohn?s disease, myocardial infarction, stroke, diabetes, cartilage defects, and many others. The increasing number of clinical trials globally indicates the likely therapeutic potential of this specialized adult stem cell.  Over the last decade, there has been tremendous progress towards understanding an MSC?s phenotype, expansion features in culture, differentiation ability and global gene and protein expression profiles.  Despite the enormous progress and data accrual at the molecular and cellular levels, several questions remain as to the utility of MSCs for clinical applications. 

 

Mesenchymal Stem Cell Therapy is a comprehensive collection of information comprised of both basic and pre-clinical biological studies as well as current advances in clinical applications within the MSC therapy field.  This text is a resource for both the basic life science and cell therapy researchers and includes a spectrum of review chapters from top experts in the field discussing clinical scale culture, regulatory issues, genetic engineering, disease specific applications and others.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Bibliografische Details

Titel: $listing_disp.getBaseListing().getTitle()



Zustand: Used

Beste Suchergebnisse bei AbeBooks

1.

Lucas G. Chase
Verlag: Humana Press Inc. (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Anzahl: > 20
Print-on-Demand
Anbieter
Books2Anywhere
(Fairford, GLOS, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Humana Press Inc., 2015. PAP. Buchzustand: New. New Book. Delivered from our US warehouse in 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND.Established seller since 2000. Buchnummer des Verkäufers IP-9781627039147

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 183,38
Währung umrechnen

In den Warenkorb

Versand: EUR 10,74
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

2.

Verlag: Humana Press Inc., United States (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Paperback Anzahl: 10
Print-on-Demand
Anbieter
The Book Depository
(London, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Humana Press Inc., United States, 2015. Paperback. Buchzustand: New. 2013 ed.. 235 x 155 mm. Language: English . Brand New Book ***** Print on Demand *****.Over the past decade, significant efforts have been made to develop stem cell-based therapies for difficult to treat diseases. Multipotent mesenchymal stromal cells, also referred to as mesenchymal stem cells (MSCs), appear to hold great promise in regards to a regenerative cell-based therapy for the treatment of these diseases. Currently, more than 200 clinical trials are underway worldwide exploring the use of MSCs for the treatment of a wide range of disorders including bone, cartilage and tendon damage, myocardial infarction, graft-versus-host disease, Crohn s disease, diabetes, multiple sclerosis, critical limb ischemia and many others. MSCs were first identified by Friendenstein and colleagues as an adherent stromal cell population within the bone marrow with the ability to form clonogenic colonies in vitro. In regards to the basic biology associated with MSCs, there has been tremendous progress towards understanding this cell population s phenotype and function from a range of tissue sources. Despite enormous progress and an overall increased understanding of MSCs at the molecular and cellular level, several critical questions remain to be answered in regards to the use of these cells in therapeutic applications. Clinically, both autologous and allogenic approaches for the transplantation of MSCs are being explored. Several of the processing steps needed for the clinical application of MSCs, including isolation from various tissues, scalable in vitro expansion, cell banking, dose preparation, quality control parameters, delivery methods and numerous others are being extensively studied. Despite a significant number of ongoing clinical trials, none of the current therapeutic approaches have, at this point, become a standard of care treatment. Although exceptionally promising, the clinical translation of MSC-based therapies is still a work in progress. The extensive number of ongoing clinical trials is expected to provide a clearer path forward for the realization and implementation of MSCs in regenerative medicine. Towards this end, reviews of current clinical trial results and discussions of relevant topics association with the clinical application of MSCs are compiled in this book from some of the leading researchers in this exciting and rapidly advancing field. Although not absolutely all-inclusive, we hope the chapters within this book can promote and enable a better understanding of the translation of MSCs from bench-to-bedside and inspire researchers to further explore this promising and quickly evolving field. Buchnummer des Verkäufers AAV9781627039147

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 186,80
Währung umrechnen

In den Warenkorb

Versand: Gratis
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

3.

Lucas G. Chase
Verlag: Humana Press Inc. (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Anzahl: > 20
Print-on-Demand
Anbieter
PBShop
(Secaucus, NJ, USA)
Bewertung
[?]

Buchbeschreibung Humana Press Inc., 2015. PAP. Buchzustand: New. New Book.Shipped from US within 10 to 14 business days.THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Buchnummer des Verkäufers IP-9781627039147

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 184,10
Währung umrechnen

In den Warenkorb

Versand: EUR 3,74
Innerhalb USA
Versandziele, Kosten & Dauer

4.

LUCAS G. CHASE
Verlag: Humana Press (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Paperback Anzahl: 1
Anbieter
Herb Tandree Philosophy Books
(Stroud, GLOS, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Humana Press, 2015. Paperback. Buchzustand: NEW. 9781627039147 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Buchnummer des Verkäufers HTANDREE0913470

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 186,52
Währung umrechnen

In den Warenkorb

Versand: EUR 9,54
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

5.

Lucas G. Chase
Verlag: Humana Press Jan 2015 (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Taschenbuch Anzahl: 1
Print-on-Demand
Anbieter
AHA-BUCH GmbH
(Einbeck, Deutschland)
Bewertung
[?]

Buchbeschreibung Humana Press Jan 2015, 2015. Taschenbuch. Buchzustand: Neu. 235x155x25 mm. This item is printed on demand - Print on Demand Neuware - Over the past decade, significant efforts have been made to develop stem cell-based therapies for difficult to treat diseases. Multipotent mesenchymal stromal cells, also referred to as mesenchymal stem cells (MSCs), appear to hold great promise in regards to a regenerative cell-based therapy for the treatment of these diseases. Currently, more than 200 clinical trials are underway worldwide exploring the use of MSCs for the treatment of a wide range of disorders including bone, cartilage and tendon damage, myocardial infarction, graft-versus-host disease, Crohn's disease, diabetes, multiple sclerosis, critical limb ischemia and many others. MSCs were first identified by Friendenstein and colleagues as an adherent stromal cell population within the bone marrow with the ability to form clonogenic colonies in vitro. In regards to the basic biology associated with MSCs, there has been tremendous progress towards understanding this cell population's phenotype and function from a range of tissue sources. Despite enormous progress and an overall increased understanding of MSCs at the molecular and cellular level, several critical questions remain to be answered in regards to the use of these cells in therapeutic applications. Clinically, both autologous and allogenic approaches for the transplantation of MSCs are being explored. Several of the processing steps needed for the clinical application of MSCs, including isolation from various tissues, scalable in vitro expansion, cell banking, dose preparation, quality control parameters, delivery methods and numerous others are being extensively studied. Despite a significant number of ongoing clinical trials, none of the current therapeutic approaches have, at this point, become a standard of care treatment. Although exceptionally promising, the clinical translation of MSC-based therapies is still a work in progress. The extensive number of ongoing clinical trials is expected to provide a clearer path forward for the realization and implementation of MSCs in regenerative medicine. Towards this end, reviews of current clinical trial results and discussions of relevant topics association with the clinical application of MSCs are compiled in this book from some of the leading researchers in this exciting and rapidly advancing field. Although not absolutely all-inclusive, we hope the chapters within this book can promote and enable a better understanding of the translation of MSCs from bench-to-bedside and inspire researchers to further explore this promising and quickly evolving field. 468 pp. Englisch. Buchnummer des Verkäufers 9781627039147

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 197,94
Währung umrechnen

In den Warenkorb

Versand: EUR 29,50
Von Deutschland nach USA
Versandziele, Kosten & Dauer

6.

Chase, Lucas G.
Verlag: Humana Press (2016)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Paperback Anzahl: 1
Print-on-Demand
Anbieter
Ria Christie Collections
(Uxbridge, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Humana Press, 2016. Paperback. Buchzustand: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Buchnummer des Verkäufers ria9781627039147_lsuk

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 199,06
Währung umrechnen

In den Warenkorb

Versand: EUR 3,40
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

7.

Verlag: Humana Press (2012)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Softcover Anzahl: 15
Print-on-Demand
Anbieter
English-Book-Service Mannheim
(Mannheim, Deutschland)
Bewertung
[?]

Buchbeschreibung Humana Press, 2012. Buchzustand: New. This item is printed on demand for shipment within 3 working days. Buchnummer des Verkäufers LP9781627039147

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 212,07
Währung umrechnen

In den Warenkorb

Versand: EUR 4,00
Von Deutschland nach USA
Versandziele, Kosten & Dauer

8.

Chase, Lucas G. (EDT)/ Vemuri, Mohan C. (EDT)
Verlag: Humana Press Inc. 2015-01-28, Totowa, NJ (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu paperback Anzahl: > 20
Anbieter
Blackwell's
(Oxford, OX, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Humana Press Inc. 2015-01-28, Totowa, NJ, 2015. paperback. Buchzustand: New. Buchnummer des Verkäufers 9781627039147

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 237,48
Währung umrechnen

In den Warenkorb

Versand: EUR 5,37
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

9.

Verlag: Humana Press (2015)
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu Paperback Anzahl: 1
Anbieter
Irish Booksellers
(Rumford, ME, USA)
Bewertung
[?]

Buchbeschreibung Humana Press, 2015. Paperback. Buchzustand: New. book. Buchnummer des Verkäufers 1627039147

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 271,29
Währung umrechnen

In den Warenkorb

Versand: Gratis
Innerhalb USA
Versandziele, Kosten & Dauer

10.

Verlag: Humana Press
ISBN 10: 1627039147 ISBN 13: 9781627039147
Neu PAPERBACK Anzahl: > 20
Anbieter
Russell Books
(Victoria, BC, Kanada)
Bewertung
[?]

Buchbeschreibung Humana Press. PAPERBACK. Buchzustand: New. 1627039147 Special order direct from the distributor. Buchnummer des Verkäufers ING9781627039147

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 272,40
Währung umrechnen

In den Warenkorb

Versand: EUR 6,56
Von Kanada nach USA
Versandziele, Kosten & Dauer